LXEO

Lexeo Therapeutics Inc

• TipRanks·5d ago

  Top Executive Makes Notable Move in Lexeo Therapeutics Stock

• TipRanks·05/12 18:28

  Trump Trade: Trump to suspend tariff-rate quotas on beef imports

• TipRanks·05/12 11:29

  Stifel Nicolaus Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)

• TipRanks·05/12 11:18

  Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital

• TipRanks·05/11 19:29

  Trump Trade: U.S. plans AI security order without required model tests

• TipRanks·05/11 18:20

  Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)

• Dow Jones·05/11 18:06

  Lexeo Therapeutics Is Maintained at Buy by Chardan Capital

• Dow Jones·05/11 18:06

  Lexeo Therapeutics Price Target Maintained With a $17.00/Share by Chardan Capital

• TipRanks·05/11 17:54

  Trump approves plan to fire FDA head Marty Makary, CBS reports

• TipRanks·05/11 12:34

  Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c)

• Seeking Alpha·05/11 12:30

  Lexeo Therapeutics GAAP EPS of -$0.25

• TipRanks·05/11 11:36

  Lexeo Highlights Q1 Progress Advancing Cardiac Gene Therapies

• Dow Jones·05/11 11:05

  *Lexeo Therapeutics 1Q Loss $20.2M >LXEO

• Dow Jones·05/11 11:05

  *Lexeo Therapeutics 1Q Loss/Shr 25c >LXEO

• PUBT·05/11 11:03

  Lexeo Q1 FY26 net loss narrows to $20.2 million, or $0.25 a share